A recent study showed that anti-CTLA-4 immunotherapy combined with peripheral targeted radiotherapy resulted in impaired anxiety and cognitive functions associated with neuro-inflammation and microglial activation in mice [48], but the mechanisms linking tumor and immunotherapy are not understood. The gene discussed is CTLA4; the disease is neoplasm.